Hong Kong-listed biotech stocks rose amid volatility, with Xuanzhu Bio-B (02575.HK) surging over 12%, Ascletis Pharma (01672.HK) rising over 7%, Lepu Bio (02157.HK) and XtalPi (02228.HK) rising over 6%, and Akeso Biopharma (09926.HK) rising over 5.5%.